# A Study Evaluating HC-1119 Single-Dose Pharmacokinetics and Effect of Food on Its Pharmacokinetics

> **NCT03776968** · PHASE1 · COMPLETED · sponsor: **Hinova Pharmaceuticals Inc.** · enrollment: 47 (actual)

## Conditions studied

- Metastatic Castration Resistant Prostate Cancer

## Interventions

- **DRUG:** HC1119

## Key facts

- **NCT ID:** NCT03776968
- **Lead sponsor:** Hinova Pharmaceuticals Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-24
- **Primary completion:** 2018-01-15
- **Final completion:** 2018-07-03
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2024-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03776968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03776968, "A Study Evaluating HC-1119 Single-Dose Pharmacokinetics and Effect of Food on Its Pharmacokinetics". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT03776968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*